KUALA LUMPUR (Dec 1): Duopharma Biotech Berhad has recently partnered with RenalWorks Malaysia Sdn Bhd, a subsidiary of Singapore-based RenalWorks Pte Ltd, to enhance dialysis services through the provision of the proprietary RenalGenie Electronic Health Record (EHR) dialysis software.
The RenalGenie software focuses on streamlining data flows and strengthening patient care and compliance while ensuring that healthcare facilities can provide the highest standards of service with optimised operational efficiency, said Duopharma in a statement.
“The all-in-one healthcare facility management software taps on the latest cloud-based accessibility and mobile technologies to enable remote management and overcome the challenges of installing conventional dialysis EHR systems.
“Via a comprehensive and centralised database recording up-to-date patient health data, healthcare providers are empowered with informed decision-making, with optimised healthcare facilities management and care coordination, and a user-friendly interface,” it added.
According to the statement, this partnership responds to the projected increase in kidney disease patients in Malaysia, with RenalGenie software addressing key pain points and data gaps in dialysis care.
“Malaysia is unfortunately looking at an uptick in kidney disease and kidney failure patients in the years to come, so it is important to lay the groundwork now for healthcare systems to support this future need.
“In addition, implementation of the RenalGenie EHR dialysis software is also in line with national efforts to expand digitalisation for improving healthcare service delivery and, in turn, elevate outcomes,” said Duopharma Biotech managing director Leonard Ariff Abdul Shatar.
Elaborating on the development of the RenalGenie software, RenalWorks founder and managing director Chan Wai Chuen stated, “We innovated RenalGenie to achieve new standards in patient care, safety, and outcomes with comprehensive treatment functionalities to address key pain points and data gaps in dialysis care.
“With RenalGenie, healthcare facilities can substantially reduce operational costs by streamlining workflow processes and improving revenue by applying our proprietary automated billing algorithms and scheduler to optimise healthcare facilities’ capacity utilisation.”
The software was formally introduced to healthcare providers following the recent signing of an agreement between Duopharma (M) Sdn Bhd, a subsidiary of Duopharma Biotech Berhad and RenalWorks Malaysia Sdn Bhd, said Duopharma.
Duopharma Biotech will be the exclusive sales and marketing partner for RenalGenie in Malaysia, with potential expansion to other Asean markets, it added.
At the time of writing, Duopharma Biotech shares were traded up one sen or 0.83% at RM 1.22, giving it a market capitalisation of RM1.17 billion.